Nicholas Manieri is a Principal Scientist II and drug discovery leader with extensive experience in immunology and oncology. Formerly a postdoctoral researcher at Genentech, they focused on cancer immunology, specifically the role of TIGIT and PVR-nectin in mouse models of cancer. Nicholas has held positions at notable organizations such as Johnson & Johnson, where they currently lead immune modulation and lead characterization efforts in biologics discovery. They earned a PhD in Immunology from Washington University in St. Louis, where they investigated molecular mechanisms relevant to mucosal healing.
This person is not in the org chart
This person is not in any teams
This person is not in any offices